Fanapt Schizophrenia Drug Gets FDA Approval

The US Food and Drug Administration (FDA) has approved Fanapt tablets (iloperidone) made by Patheon Inc of Mississauga, Ontario, for Vanda Pharmaceuticals Inc of Rockville, Maryland, for the treatment of adults with schizophrenia, said an announcement on the FDA website on Wednesday. The news that Vanda has won US approval for its first product sent shares in the company soaring in extended Nasdaq Stock Market trading yesterday, said the Washington Post.

More: continued here

Filed under: Pharma Industry on May 11th, 2009